Disease | rheumatoid arthritis |
Symptom | C0343192|microscopic polyangiitis |
Sentences | 2 |
PubMedID- 25973441 | Rituximab is a chimeric monoclonal antibody employed for the treatment of cd20-positive b-cell non-hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis. |
PubMedID- 25664229 | 2014)ra/gpa6567skin, lung, ent, eyerhf, c-ancamtx, prednisone, etanercept,iour report5 ra/mpa24-6363-691: kidney, lung3: rhf1: mtx, prednisone5 i1 ra/gpa5: kidney1: anti-ccp1: sfz1 hd1: pr3-anca1: hcq, mtx, leflunomide1d3: mpo-anca1: infliximab, mtx, sfz1: etanercept, mtx, sfz, aza1: prednisolonera: rheumatoid arthritis, gpa: granulomatosis with polyangiitis, mpa: microscopic polyangiitis, egpa (churg-strauss syndrome), ent: ear, nose and throat; hcq: hydroxychloroquine, nsaid: non-steroidal anti-inflammatory drug, cp: cyclophophamide; aza: azathioprine, sfz: sulfasalazine, mtx: methotrexate, d: dead, i: aav improved, hd: hemodialysis. |
Page: 1